Related Experiment Videos
High-density lipoproteins and atherosclerosis
1University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. rader@mail.med.upenn.edu
Insights
High-density lipoproteins (HDL) are crucial for cardiovascular health. Research explores HDL metabolism and its role in preventing atherosclerosis, a key factor in heart disease.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Atherosclerosis Research
Background:
- High-density lipoproteins (HDL) are linked to atherosclerotic cardiovascular disease risk.
- Low HDL cholesterol is a significant cardiovascular risk factor.
- Apolipoprotein (apo) A-I overexpression inhibits atherosclerosis in animal models.
Purpose of the Study:
- To investigate the role of HDL in atherosclerosis.
- To understand the mechanisms by which HDL inhibits atherosclerosis.
- To evaluate HDL as a therapeutic target for cardiovascular disease.
Main Methods:
- Review of existing clinical and animal model data on HDL and atherosclerosis.
- Analysis of gene products involved in HDL metabolism regulation.
- Exploration of the relationship between HDL, atherosclerosis, and cardiovascular risk factors.
Main Results:
- HDL is strongly associated with atherosclerotic cardiovascular disease risk.
- Low HDL cholesterol levels are a major cardiovascular risk factor.
- Overexpression of apo A-I reduces atherosclerosis progression and induces regression in animal models.
Conclusions:
- HDL is a potential therapeutic target for cardiovascular disease.
- Further research is needed to fully understand HDL metabolism and its role in atherosclerosis.
- Understanding HDL's mechanisms is crucial for developing effective cardiovascular therapies.
Abstract:
High-density lipoproteins (HDLs) are strongly related to risk of atherosclerotic cardiovascular disease. Low levels of HDL cholesterol are a major cardiovascular risk factor, and overexpression of the major HDL protein, apolipoprotein (apo) A-I, markedly inhibits progression and even induces regression of atherosclerosis in animal models. Clinical data regarding the effect of increasing HDL cholesterol on vascular events are limited. HDL remains an important potential target for therapeutic intervention. A variety of gene products are involved in the regulation of HDL metabolism. Yet, the mechanisms by which HDL inhibits atherosclerosis are not yet fully understood. There remains much to be learned about HDL metabolism and its relation to atherosclerosis and other cardiovascular risk factors.